纯化重组蛋白
Santa Cruz Biotechnology offers purified recombinant proteins for in vitro research use. Recombinant proteins are created by cloning a fragment of exogenous DNA into a vector. Using molecular cloning technology, recombinant DNA (rDNA) is generated and introduced into a living cell. The rDNA is later transcribed into mRNA and translated by the host machinery. Note the mRNA generated in prokaryotes is considered "mature" and will not go through further processing unlike eukaryotes where the pre-mRNA transcript goes through 5' cap addition, splicing and polyadenylation.
関連項目
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
| Empty Table Header | 产品名称 | 目录 | 数量 | Species | 应用 | 排名 |
|---|---|---|---|---|---|---|
4E-BP1 (FL) | sc-4251 | 50 µg | r | 2 | ||
Adenovirus-2 E1A (13S) | sc-4021 | 50 µg | Adenovirus-2 | 1 | ||
ARG1/Arginase 1 (271-332) WB | sc-4496 WB | 10 µg/0.1 ml | h | 0 | ||
Bad (FL) | sc-4702 | 50 µg | h | 0 | ||
Bak (FL-211) | sc-4272 WB | 10 µg/0.1 ml | h | 0 | ||
Bax (1-171) WB | sc-4239 WB | 10 µg/0.1 ml | m | 1 | ||
Bcl-6 (3-484) | sc-4105 | 50 µg | h | 0 | ||
BDNF (hBA-238) | sc-4554 | 50 µg | h | 6 | ||
GENIUS™ Nuclease, 25 KU | sc-202391 | 25 KU | 45 | |||
β-defensin 2 (hBA-41) | sc-4835 | 50 µg | h | 0 | ||
β-defensin 3 (hBA-45) | sc-4836 | 50 µg | h | 0 | ||
Myc (1-262) | sc-4084 | 50 µg | h | 15 | ||
CD154 (hBA-149) | sc-4557 | 50 µg | h | 1 | ||
CD64 (125-374) | sc-4370 WB | 10 µg/0.1 ml | h | 0 | ||
Collagen I, human | sc-136154 | 10 mg | 2 | |||
Collagen I, rat tail (3-5 mg/ml) | sc-136157 | 100 mg | 16 | |||
Collagen I, rat tail (8-11 mg/ml), 100 mg | sc-506257 | 100 mg | 0 | |||
cyclin B1 (1-433) | sc-4073 WB | 10 µg/0.1 ml | h | 1 | ||
cyclin D1 (1-295) | sc-4074 WB | 10 µg/0.1 ml | h | 1 | ||
EGF (hBA-53) | sc-4552 | 500 µg | h | 3 | ||
EGF (mBA-53) | sc-4848 | 500 µg | m | 1 | ||
Extracellular Matrix | sc-136155 | 1 mg | 1 | |||
FAK (Δ 902) | sc-4107 | 50 µg | m | 0 | ||
FAS (hBA-157) | sc-4856 | 50 µg | h | 0 | ||
FAS-L (hBA-175) | sc-4855 | 50 µg | h | 1 | ||
FGF-2 (hBA-154) | sc-4573 | 50 µg | h | 6 | ||
VEGFR2 (1158-1345) | sc-4058 WB | 10 µg/0.1 ml | m | 0 | ||
Flk-1/KDR/VEGFR2 | sc-4059 WB | 10 µg/0.1 ml | m | 0 | ||
G-CSF (hBA-174) | sc-4583 | 50 µg | h | 1 | ||
G-CSF (mBA-179) | sc-4584 | 50 µg | m | 0 | ||
GADD 153 (1-168) | sc-4066 WB | 10 µg/0.1 ml | m | 0 | ||
GAL4 (DBD 1-147) | sc-4050 | 50 µg | 6 | |||
GDNF (78-211) | sc-4312 WB | 10 µg/0.1 ml | h | 0 | ||
GFP (1-238) | sc-4304 WB | 10 µg/0.1 ml | Aequorea victoria | 2 | ||
GH 抗体 (hBA-192) | sc-4621 | 500 µg | h | 0 | ||
GM-CSF (hBA-127) | sc-4585 | 50 µg | h | 0 | ||
GM-CSF (mBA-125) | sc-4622 | 50 µg | m | 0 | ||
GST (1-218) | sc-4033 | 50 µg | Schistosoma japonicum | 7 | ||
HGF (hBA-170) | sc-4970 | 10 µg | h | 1 | ||
IκB-α (1-317) | sc-4094 | 50 µg | h | 53 | ||
Id1 (1-148) | sc-4020 WB | 10 µg/0.1 ml | m | 0 | ||
IFN-α2a 抗体 (hBA-165) | sc-4623 | 100 µg | h | 1 | ||
IFN-γ/Interferon gamma | sc-4587 | 100 µg | h | 1 | ||
IGF-I (BA-m70) | sc-4590 | 50 µg | m | 1 | ||
IGF-I (hBA-70) | sc-4589 | 100 µg | h | 1 | ||
IL-1α (hBA-159) | sc-4591 | 50 µg | h | 1 | ||
IL-1β (hBA-153) | sc-4592 | 50 µg | h | 3 | ||
IL-13 (hBA-114) | sc-4606 | 50 µg | h | 1 | ||
IL-15 (mBA-115) | sc-4895 | 50 µg | m | 0 | ||
IL-17 抗体 (hBA-136) | sc-4610 | 25 µg | h | 0 | ||
IL-2 (hBA-133) | sc-4593 | 50 µg | h | 1 | ||
IL-4 (hBA-129) | sc-4595 | 50 µg | h | 1 | ||
IL-6 (hBA-184) | sc-4597 | 50 µg | h | 3 | ||
IL-8 抗体 (hBA-72) | sc-4600 | 50 µg | h | 1 | ||
JNK1 (1-384) | sc-4061 | 50 µg | h | 2 | ||
LIF (hBA-FL) | sc-4377 | 50 µg | h | 9 | ||
LIF (hBA) | sc-4988 | 106 units (10 µg) | h | 2 | ||
LIF (mBA-FL) | sc-4378 | 50 µg | m | 15 | ||
LIF (mBA) | sc-4989 | 106 units (10 µg) | m | 4 | ||
Mad 1 (1-221) | sc-4086 WB | 10 µg/0.1 ml | h | 0 | ||
MEK-1 (FL) | sc-4025 | 50 µg | h | 17 | ||
Metallothionein (1-61) | sc-4293 | 50 µg | h | 0 | ||
MyoD (1-318) | sc-4080 | 50 µg | m | 3 | ||
NFκB p50 (120-239) | sc-4432 WB | 10 µg/0.1 ml | h | 0 | ||
NT-3 (hBA-119) | sc-4942 | 50 µg | h | 1 | ||
Ob (hBA-147) | sc-4912 | 1000 µg | h | 1 | ||
OLIG2 (11-78) | sc-4982 | 50 µg | h | 0 | ||
CDKN2A/p16 (1-156) | sc-4079 | 50 µg | h | 1 | ||
CDKN2A/p16 (1-168) WB | sc-4995 WB | 10 µg/0.1 ml | h | 0 | ||
p53 (1-393) | sc-4246 | 50 µg | h | 28 | ||
PDGF-A (hBA-124) | sc-4946 | 50 µg | h | 1 | ||
PDGF-B (hBA-108) | sc-4948 | 50 µg | h | 0 | ||
PDGF Receptor alpha/PDGFRA (AG-1) | sc-4031 WB | 10 µg/0.1 ml | h | 0 | ||
Pit-1 (FL) | sc-4014 | 50 µg | r | 1 | ||
RAGE (1-300) | sc-4527 WB | 10 µg/0.1 ml | h | 0 | ||
RANTES (hBA-68) | sc-4637 | 50 µg | h | 0 | ||
RANTES (mBA-68) | sc-4952 | 50 µg | m | 0 | ||
Rb (769) | sc-4112 | 50 µg | m | 65 | ||
Sam 68 (331-443) | sc-4249 | 50 µg/50 µl | m | 10 | ||
SDF-1α/CXCL12 | sc-4654 | 50 µg | h | 2 | ||
Shc-SH2 (366-473) | sc-4110 WB | 10 µg/0.1 ml | h | 0 | ||
Smad3 (FL) | sc-4709 | 50 µg | h | 1 | ||
TFIIB | sc-4001 | 50 µg | h | 15 | ||
TFIIE-β (p34) | sc-4029 WB | 10 µg/0.1 ml | h | 0 | ||
TGFβ1 (hBA-112) | sc-4561 | 50 µg | h | 4 | ||
TNF-R1 (hBA-162) | sc-4566 | 50 µg | h | 2 | ||
TNF alpha | sc-4564 | 50 µg | h | 6 | ||
TNF alpha | sc-4890 | 50 µg | m | 0 | ||
TRAIL (hBA-168) | sc-4547 | 50 µg | h | 2 | ||
Ubiquitin Aldehyde, 50 µg | sc-4316 | 50 µg | 19 | |||
VEGF (hBA-165) | sc-4570 | 50 µg | h | 7 | ||
VEGF (mBA-165) | sc-4571 | 50 µg | m | 10 |